Author Index: H

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Haas, D. W.
• COST-EFFECTIVENESS ANALYSIS OF CYP2B6 GENETIC TESTING TO INFORM EFAVIRENZ DOSE REDUCTION FOR INITIAL HIV THERAPY
Hagen, G.
• CALCIUM AND VITAMIN D FOR HIP FRACTURE PREVENTION IN LIGHT OF POSSIBLE CARDIOVASCULAR SIDE EFFECTS
Hajizadeh, N.
• SYMPOSIUM: WHAT SHOULD THE ROLE OF CEA BE IN HEALTH POLICY AND MEDICAL DECISION MAKING?
• INSIGHTS FROM FUNDING AGENCIES
Hajizadeh, N.
• USABILITY TESTING OF “INFORMEDTOGETHER”, A WEB-BASED DECISION AID TO FACILITATE SHARED ADVANCE DIRECTIVE PLANNING FOR SEVERE COPD
• SMDM CORE COURSE: AN INTRODUCTION THE PSYCHOLOGY OF MEDICAL DECISION MAKING
Hakendorf, P.
• COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM QUALITY IMPROVEMENT USING LINKED COSTS, OUTCOMES, AND PROCESS DATA
Hall, B.
• IMPROVED SURVIVAL WITH TELEPHONIC CARE MANAGEMENT
Halpern, S.
• THINKING FORWARD: THE TIME ORIENTATION OF PATIENTS MAKING TREATMENT DECISIONS
Halvorsen, P. A.
• CONTINUITY OF THE DOCTOR-PATIENT RELATIONSHIP MAY INFLUENCE DECISIONS TO SEE A COMPLEMENTARY AND ALTERNATIVE MEDICAL CARE PROVIDER
Hamilton, B.
• IN VITRO FERTILIZATION INSURANCE COVERAGE AND CHANCES OF A LIVE BIRTH
Hannibal, K.
• A 2-YEAR RANDOMIZED CLUSTER TRIAL TO IMPROVE CHILDHOOD INFLUENZA VACCINATION
Hanoch, Y.
• A TAILORED APPROACH TO RISK COMMUNICATION IN DECISION AIDS: FINDING THE OPTIMAL FORMAT FOR INDIVIDUALS
Hansen, A. H.
• CONTINUITY OF THE DOCTOR-PATIENT RELATIONSHIP MAY INFLUENCE DECISIONS TO SEE A COMPLEMENTARY AND ALTERNATIVE MEDICAL CARE PROVIDER
Hansen, P.
• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)
Haratsidis, E.
• IMPLEMENTATION CHALLENGES OF A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN WOUND CARE
Harinck, F.
• EXPLORING THE EFFECTS OF FACTORS ASSOCIATED WITH THE OUTCOME OF PANCREATIC CANCER SCREENING IN HIGH-RISK INDIVIDUALS BY THE USE OF A MICROSIMULATION MODEL
Harnett, B.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Harris, M.
• HEALTH RISK ASSESSMENT SOFTWARE FOR EVERYONE: TESTING THE ASSOCIATION OF NUMERACY WITH ENGAGEMENT, PERCEIVED USEFULNESS AND SATISFACTION
Harris, R.
• TESTING A COLORECTAL CANCER SCREENING DECISION AID TARGETED TO OLDER ADULTS
Harris, R.
• FINDINGS FROM A SYSTEMATIC REVIEW OF ALTERNATE STRATEGIES FOR COMMUNICATING THE UNCERTAINTY OF MEDICAL EVIDENCE
Harrison, M.
• DOES INTRODUCING IMPRECISION AROUND PROBABILITIES FOR BENEFIT AND HARM INFLUENCE THE WAY PEOPLE VALUE TREATMENTS?
Hart, J.
• THINKING FORWARD: THE TIME ORIENTATION OF PATIENTS MAKING TREATMENT DECISIONS
Hartemink, K.
• PATIENT'S PREFERENCE FOR SURGERY OR STEREOTACTIC ABLATIVE RADIOTHERAPY FOR STAGE I NON-SMALL CELL LUNG CANCER: A CONJOINT ANALYSIS OF TREATMENT DECISIONS
Harutyunyan, T.
• HOW FAMILY-BASED COUNSELING/EDUCATION CAN IMPACT THE HEALTH OF PATIENTS WITH TUBERCULOSIS IN ARMENIA, 2013
Harvey, M. J.
• THE MARGINAL COST-EFFECTIVENESS OF CHILDHOOD VACCINATION COVERAGE
Hatfield, L.
• HANDLING MISSING DATA IN META-ANALYSIS OF INDIVIDUAL PARTICIPANT DATA WITH MIXED OUTCOMES
Hauber, A. B.
• SYMPOSIUM: APPLYING STATED-PREFERENCE METHODS AMONG DIVERSE PATIENT GROUPS
• A BEGINNERS’ GUIDE TO THE ART AND SCIENCE OF STATED-PREFERENCE METHODS
Hawkins, G.
• BEST-WORST SCALING ALLOWS US TO QUANTIFY ATTITUDES AS WELL AS PREFERENCES; RESPONSE TIMES TELL US WHICH ARE "GUT" ATTITUDES WITH NO PREDICTIVE POWER
Hawkins, K.
• DISPARITIES AMONG THOSE WITH ADVANCE DIRECTIVES IN A MEDICARE SUPPLEMENT POPULATION
Hawkins, N.
• AN INTRODUCTION TO THE DEVELOPMENT AND USE OF CONCEPTUAL MODELS
Hawkins, N.
• IMPROVING THE EXTRAPOLATION OF SURVIVAL DATA; HOW SHOULD WE EXPLOIT ADDITIONAL DATA?
Hawley, S. T.
• FACTORS ASSOCIATED WITH DECISIONS FOR CONTRALATERAL PROPHYLACTIC MASTECTOMY
Hayes, M. K. A.
• COST AND POLICY IMPLICATIONS OF ADOPTION OF NEW RADIOTHERAPY TECHNOLOGY FOR BREAST CANCER
Hayward, R.
• TRANSPARENCY ABOUT BENEFITS AND HARMS IS UNCOMMON IN RECOMMENDATIONS ON CANCER SCREENING & PREVENTION
He, T.
• HEPATITIS C PREVENTION BY SCREENING AND TREATMENT IN UNITED STATES PRISONS: AN AGENT-BASED APPROACH
Heffner, J. L.
• HOW DOES LUNG CANCER SCREENING INFLUENCE PATIENT ATTITUDES ABOUT QUITTING SMOKING? AN EXAMINATION OF PATIENT REACTIONS WHEN SCREENING IS IMPLEMENTED IN PRIMARY CARE
Heijnsdijk, E. A. M.
• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
Heike, C.
• THE COST-EFFECTIVENESS OF SCREENING ECHOCARDIOGRAMS IN INFANTS WITH CRANIOSYNOSTOSIS UNDERGOING CRANIAL VAULT EXPANSION
Heisler, M.
• TRANSPARENCY ABOUT BENEFITS AND HARMS IS UNCOMMON IN RECOMMENDATIONS ON CANCER SCREENING & PREVENTION
Hellemann, G.
• EFFECTIVENESS OF COMPUTERIZED WEIGHT MANAGEMENT WITH PEER SUPPORTS FOR PEOPLE WITH MENTAL ILLNESS
Hendrix, K. S.
• DOES COLOR-HIGHLIGHTING CLINICAL DECISION SUPPORT REMINDERS IMPROVE PHYSICIANS' RESPONSIVENESS?
• USING CONJOINT ANALYSIS TO ASSESS THE RELATIVE INFLUENCE OF RESUSCITATION PREFERENCES ON OBSTETRICAL MANAGEMENT OF PERIVIABLE DELIVERIES
Henry, S.
• BOOKLET TALK: PATIENT USE OF DECISION AIDS IN PROSTATE CANCER DIAGNOSIS ENCOUNTERS
Heru, S.
• SOCIETAL AND POLICY IMPLICATIONS FOR MEDICALLY NECESSARY SERVICES AND PREVENTIVE CARE IN THE U.S. TRANSGENDER POPULATION: A COST-EFFECTIVENESS ANALYSIS
Hess, R.
• SYMPOSIUM: THE LEARNING HEALTH CARE SYSTEM: USING BIG DATA TO IMPROVE SYSTEMS & ADVANCE CARE IN COMMUNITIES
Hicks, L. K.
• COST-EFFECTIVENESS OF HEPATITIS B VIRUS SCREENING BEFORE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH EARLY STAGE BREAST CANCER
Hillege, H. L.
• THE APPLICATION OF CONTINUOUS-TIME SEMI-MARKOV MODELS IN HEALTH ECONOMIC DECISION MAKING: A CASE STUDY IN HEART FAILURE DISEASE MANAGEMENT
• VALUE AND UTILITIES AMONG EUROPEAN PATIENTS: A DECISION-ANALYTIC TOOL FOR MEASURING PATIENT PREFERENCES
Hinahara, J.
• HETEROGENEITY IN MARKOV MODELS OF THE NATURAL HISTORY OF DISEASE: INVESTIGATING ONCOGENICITY
Hipólito-Olivares, C.
• HEALTH CARE DECISION MAKING IN MEXICO: THE ROLE OF HEALTH TECHNOLOGY ASSESSMENT AND ECONOMIC EVALUATION
Hite, A. W.
• CANCELLED: DOES ANIMATION IMPROVE COMPREHENSION OF RISK INFORMATION IN PATIENTS WITH LOW HEALTH LITERACY?
Hlatky, M. A.
• COST-EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY COMPARED WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ALONE IN MILD HEART FAILURE
Ho, T.
• ERLOTINIB, AFATINIB, AND CISPLATIN/PEMETREXED FOR FIRST-LINE TREATMENT OF ADVANCED EGFR-MUTATION POSITIVE NON-SMALL CELL LUNG CANCER: VALUE-OF-INFORMATION ANALYSIS
Hoch, J. S.
• ESTIMATING HEALTHCARE COSTS FOR DECISION-ANALYTIC MODELS IN ATRIAL FIBRILLATION USING ADMINISTRATIVE DATA
• SMDM CORE COURSE: INTRODUCTION TO COST-EFFECTIVENESS ANALYSIS
Hockenberry, J.
• COGNITIVE INERTIA AND TECHNOLOGICAL ABANDONMENT IN MEDICINE
Hodgson, S.
• PARENTAL RISK PERCEPTION AND DECISION MAKING REGARDING VACCINATION OF THEIR ELIGIBLE CHILDREN WITH THE HUMAN PAPILLOMAVIRUS VACCINE
Hoes, A.
• SHOULD PATIENTS PRESCRIBED LONG-TERM LOW-DOSE ASPIRIN RECEIVE PROTON PUMP INHIBITORS? SYSTEMATIC REVIEW AND META-ANALYSIS
Hoff, G.
• DEVELOPMENT AND VALIDATION OF A NORWEGIAN MODEL FOR COLORECTAL CANCER
Hoffman, A.
• USING A WEB-BASED PATIENT REPORTED OUTCOMES TOOL (MYPSYCKES) TO ASSESS MENTAL HEALTH PATIENTS' INTEREST IN ALTERNATIVE THERAPIES AND RELATED CONCERNS
• DEVELOPING AND EVALUATING A WEB-BASED PATIENT REPORTED OUTCOMES AND DECISION SUPPORT TOOL (MYPSYCKES)
• CONSUMER USABILITY TESTING OF A WEB-BASED PATIENT REPORTED OUTCOMES (PROS) AND DECISION SUPPORT TOOL (MYPSYCKES): IMPORTANT LESSONS FOR PROS SYSTEMS
• USING A WEB-BASED PATIENT REPORTED OUTCOMES PROGRAM (MYPSYCKES) TO EXAMINE PATIENT SMOKING STATUS AND INTEREST IN CESSATION SUPPORT
Hoffman, A. S.
• DESIGNING DEMENTIA DECISION AIDS: HOW DO WE MEET THE DIFFERING NEEDS OF PATIENTS, CAREGIVERS, AND CARE PROVIDERS?
Hofstede, S. N.
• REASONS FOR ORTHOPAEDIC SURGEONS TO PROVIDE RECOMMENDED NON-SURGICAL TREATMENTS TO PATIENTS WITH HIP OR KNEE OSTEOARTHRITIS
Hogan, C.
• THE COST OF PERMANENT PACEMAKER IMPLANTATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT
Holl, J.
• COST MINIMIZATION OF AFTER HOURS POSTOPERATIVE CARE FOR TRANSPLANT RECIPIENTS
Hollenbeck, B. K.
• REGIONALIZATION OF HIGH RISK SURGERIES AND ITS IMPLICATION ON OUTCOME AND SURGICAL CARE SUPPLY REGULATION
Hollin, I.
• COMPARING BEST WORST SCALING AND CONJOINT ANALYSIS TO MEASURE CAREGIVER PREFERENCES FOR THE BENEFITS AND RISKS OF EMERGING TREATMENTS FOR DUCHENE MUSCULAR DYSTROPHY
Holloway, R.
• PERSPECTIVE INSTRUCTIONS TO INCREASE STUDENT EMPATHY IN MEDICAL DECISION MAKING
Holmberg, C.
• “MY LIVED EXPERIENCES ARE MORE IMPORTANT THAN YOUR PROBABILITIES”: DECISION NARRATIVES IN THE STUDY OF TAMOXIFEN AND RALOXIFENE (STAR)
Holmes, J. H.
• PARTICIPATORY DESIGN OF A PATIENT DECISION AID IN TREATMENT CHOICE FOR PERINATAL DEPRESSION
Holmes-Rovner, M.
• BOOKLET TALK: PATIENT USE OF DECISION AIDS IN PROSTATE CANCER DIAGNOSIS ENCOUNTERS
• IF YOU BUILD THE FIELDS OF SHARED DECISION MAKING DREAMS, CAN PROSTATE CANCER PATIENTS PLAY?
Holmes-Rovner, M.
• PARTICIPATORY DESIGN OF A PATIENT DECISION AID IN TREATMENT CHOICE FOR PERINATAL DEPRESSION
Holodniy, M.
• COST-EFFECTIVENESS ANALYSIS OF SOFOSBUVIR-BASED TREATMENT FOR CHRONIC, GENOTYPE 1 HEPATITIS C INFECTIONS IN U.S. INCARCERATED POPULATIONS
Hooper, D.
• INCORPORATION OF PATIENT COLONIZATION WITH VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND PATIENT ACUITY INTO A DISCRETE EVENT SIMULATION MODEL OF INPATIENT BED ALLOCATION AND PATIENT FLOW
Hopmans, W.
• PATIENT'S PREFERENCE FOR SURGERY OR STEREOTACTIC ABLATIVE RADIOTHERAPY FOR STAGE I NON-SMALL CELL LUNG CANCER: A CONJOINT ANALYSIS OF TREATMENT DECISIONS
Horsfall, M.
• COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM QUALITY IMPROVEMENT USING LINKED COSTS, OUTCOMES, AND PROCESS DATA
Hortal, M.
• ESTIMATING THE COSTS OF INVASIVE PNEUMOCOCCAL DISEASE IN OLDER CHILDREN AND ADULTS IN SELECTED COUNTRIES OF LATIN AMERICA
Hoskins, D.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Hou, T.
• INCORPORATION OF PATIENT COLONIZATION WITH VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) AND PATIENT ACUITY INTO A DISCRETE EVENT SIMULATION MODEL OF INPATIENT BED ALLOCATION AND PATIENT FLOW
Howard, D. H.
• PRICING IN THE MARKET FOR ANTICANCER DRUGS
• COGNITIVE INERTIA AND TECHNOLOGICAL ABANDONMENT IN MEDICINE
Hozo, I.
• EMPIRICAL EVALUATION OF THE ACCEPTABLE REGRET MODEL OF MEDICAL DECISION- MAKING
• UNCERTAINTY ABOUT EFFECTS IS A KEY FACTOR INFLUENCING INSTITUTIONAL REVIEW BOARDS' APPROVAL OF CLINICAL STUDIES
Hsu, C. H.
• PATIENTS' TRUST FOR INVOLVEMENT IN SHARED DECISION MAKING: A LONGITUDINAL STUDY
Hsu, S.
• CHANGES IN HEALTH-RELATED QUALITY OF LIFE AMONG CANCER SURVIVORS: A POPULATION ANALYSIS
Hu, X.
• USING A WEB-BASED PATIENT REPORTED OUTCOMES TOOL (MYPSYCKES) TO ASSESS MENTAL HEALTH PATIENTS' INTEREST IN ALTERNATIVE THERAPIES AND RELATED CONCERNS
• USING A WEB-BASED PATIENT REPORTED OUTCOMES PROGRAM (MYPSYCKES) TO EXAMINE PATIENT SMOKING STATUS AND INTEREST IN CESSATION SUPPORT
Huang, E. S.
• GEOGRAPHIC VARIATION IN RESPONSE TO FDA WARNINGS: EVIDENCE FROM A NATIONALLY INTEGRATED SYSTEM
• PATIENTS' FUTURE EXPECTATIONS ABOUT DIABETES AND HYPERTENSION: THE ON TIME STUDY
• HOW INFORMATION ON TIMING OF GLUCOSE AND BLOOD PRESSURE CONTROL AFFECTS PATIENT DECISION-MAKING IN DIABETES: THE ON-TIME STUDY
• LONGITUDINAL GLUCOSE LOWERING TREATMENT PATTERNS IN METFORMIN MONOTHERAPY INITIATORS: IMPLICATIONS FROM A REAL-WORLD SETTING
Huang, H. H.
• A 2-YEAR RANDOMIZED CLUSTER TRIAL TO IMPROVE CHILDHOOD INFLUENZA VACCINATION
Hughes-Large, J.
• DOES FIRST LINE THERAPY WITH AROMATASE INHIBITORS INCREASE THE RISK OF HIP FRACTURES AMONG POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER? A META-ANALYSIS
Huitfeldt, A.
• USING OBSERVATIONAL DATA TO EMULATE RANDOMIZED TRIALS OF SURVEILLANCE INTERVENTIONS: AN APPLICATION TO COLORECTAL CANCER
Hunick, M.
• HOW-TO HANDS-ON WORKSHOP: PRESENTATION SKILLS
• HOW-TO HANDS-ON WORSHOP: PRESENTATION SKILLS
Hupert, N.
• PERCEPTION OF SURGICAL SITE INFECTION RISK FACTORS FOR SPINE SURGERY VARIES BY OPERATIVE TEAM ROLE
Hussain, S.
• PATIENT-SPECIFIC PHARMACOGENOMIC RESULTS DELIVERED VIA A GENOMIC PRESCRIBING DECISION SUPPORT SYSTEM STRONGLY INFLUENCE PHYSICIAN MEDICATION DECISION-MAKING AND PRESCRIBING BEHAVIORS
Husson, O.
• DISSATISFACTION WITH INFORMATION PROVISION IS ASSOCIATED WITH WORSE QUALITY OF LIFE AND ILLNESS PERCEPTION AMONG PROSTATE CANCER SURVIVORS: RESULTS FROM THE PROFILES REGISTRY
• DECISIONAL CONFLICT IN PROSTATE CANCER TREATMENT DECISION MAKING: HOW EFFECTIVE IS INFORMATION PROVISION?
Hutchins, R.
• QUANTIFYING THE DISUTILITY OF TAKING PILLS FOR PREVENTING HEART DISEASE
Hutton, D. W.
• THE MARGINAL COST-EFFECTIVENESS OF CHILDHOOD VACCINATION COVERAGE
• PROBABILISTIC DECISION ANALYTIC MODELS IN EXCEL
Huynh, E.
• BEST-WORST SCALING ALLOWS US TO QUANTIFY ATTITUDES AS WELL AS PREFERENCES; RESPONSE TIMES TELL US WHICH ARE "GUT" ATTITUDES WITH NO PREDICTIVE POWER
Hwang, E.
• SYMPOSIUM: WHAT SHOULD THE ROLE OF CEA BE IN HEALTH POLICY AND MEDICAL DECISION MAKING?
Hyder, A.
• DEVELOPMENT AND VALIDATION OF A MICROSIMULATION MODEL TO EVALUATE THE COST-EFFECTIVENESS OF INNOVATIVE SCREENING AND SURVEILLANCE FOR EARLY DETECTION OF ESOPHAGEAL ADENOCARCINOMA
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z